Promoter group entity acquires 223 shares of Ishita Drugs

Promoter Stake BuyOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.7%1-day move

₹76.60

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-2.7-3.4-2.7-1.4-4.6-4.6-7.3-2.3——

Up moveDown movePending

AI summary

Ishita Pharmaceuticals, a related party and promoter group entity of Ishita Drugs and Industries, acquired 223 shares of Rs 10 each through open market on June 22, 2026. The entity's stake rose marginally from 1.09 percent (32,697 shares) to 1.10 percent (32,920 shares). The acquisition is negligible in size and well below takeover disclosure thresholds.

Likely market impact

Marginal 0.01 percent stake increase by promoter group entity; no material impact on shareholding or stock price.